Active ingredientSultamicillinCat. No. P-S129-001CAS 76497-13-7Family · Pharmaceutical analytical standards
Sultamicillin
An oral antibiotic that joins ampicillin and the beta-lactamase inhibitor sulbactam into a single molecule; patented in 1979 and approved in 1987, it is used for respiratory, urinary, skin and soft tissue infections. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?It is a mutual prodrug: the two molecules are joined by a methylene bridge that enzymes in the gut wall break, releasing ampicillin and sulbactam in equal amounts.
Go to the active ingredient →Active ingredientSultamicillinCat. No. P-S129-001CAS 76497-13-7
Active ingredientSultamicillin TosylateCat. No. P-S129-003CAS 83105-70-8
Pharmacopoeial impuritySultamicillin EP Impurity DCat. No. P-S129-004
Pharmacopoeial impuritySultamicillin EP Impurity ECat. No. P-S129-005
Pharmacopoeial impuritySultamicillin EP Impurity FCat. No. P-S129-006
Pharmacopoeial impuritySultamicillin EP Impurity GCat. No. P-S129-007
Pharmacopoeial impuritySultamicillin Tosilate Dihydrate EP Impurity ECat. No. P-S129-008
ImpuritySultamicillin Impurity 1Cat. No. P-S129-009No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceSultamicillin CRSEDQM code Y0000530Family SultamicillinReference substanceSultamicillin tosilate CRSEDQM code Y0000531Family SultamicillinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.